I-Vitamin B17 yigama elivame ukusetshenziswa igama elibizwa nge-amygdalin. Ngokuvamile zivunyiwe ezigodini ze-apricot nama-alimondi abuhlungu, i-amygdalin isetshenziselwa ukwenza i-laetrile (i-compound ithi isisiza ukwelashwa komdlavuza). Nakuba zivame ukubizwa ngokuthi "i-vitamin B17," akuyona i-amygdalin noma i-laetrile ngempela i-vitamin B.
Isebenzisa i-Vitamin B17
I-Laetrile ivame ukubizwa ukuthi ilapha umdlavuza ngokwemvelo.
Akuvunyelwanga yi-US Food and Drug Administration njengokwelashwa komdlavuza, noma yimuphi omunye umuthi wezokwelapha.
Abanye abaxhasi be-laetrile basikisela ukuthi umdlavuza uvela ngenxa yokuntuleka kwevithamini. Abagqugquzeli abanjalo bathi ukusetshenziswa kwe-okuthiwa i-vitamin B17 kungaphazamisa lokhu okuntulekayo, futhi futhi, ukusiza ekwelapheni noma ekuvimbeleni umdlavuza. Kodwa-ke, njengoba i-National Cancer Institute (NCI) ithi, abukho ubufakazi bokuthi i-laetrile iyadingeka ngumzimba noma ukuthi i-laetrile ingaba njenge-vitamin ezilwaneni noma kubantu.
I-Laetrile nayo ihloselwe ukuvikela ngokumelene nezimo ezinjenge- high blood pressure kanye ne- arthritis .
Imithombo ye-Vitamin B17
U-Amygdalin utholakala ngokwemvelo ngamantongomane aluhlaza nasemigodini yezithelo eziningi. Kukhona nasezitshalweni ezinjengamafutha omayini, i-clover, namabele.
Imiphumela Yomphumela Nezokuphepha Ukukhathazeka
U-Amygdalin ukhiqiza i-cyanide, okuyisici esinobuthi. I-Cyanide icatshangwa ukuthi iyinhloko yomdlavuza oyinhloko we-laetrile ne-amygdalin.
Kuthiwa i-cyanide ekhishwe emzimbeni yizi zinto zingabulala amaseli omdlavuza.
Ethuthukiswe e-United States ngawo-1950, i-laetrile kuthiwa iyenzeka njenge-amygdalin engahlosiwe. Noma kunjalo, i-laetrile itholakale ukuthi idale imiphumela eminingi yemiphumela efana neyomuthi we-cyanide.
Ukusetshenziswa kwe-laetrile kuhlotshaniswa nemiphumela emibi elandelayo: umbala okwesibhakabhaka wesikhumba, ukudideka, ukuhamba nobunzima, isiyezi, ama-eyelidi angenhla, ama-headache, ukulimala kwesibindi, ukucindezelwa kwegazi okuphansi, ukucabangela kwesibindi, ukulimala kwesisindo nokuhlanza. Uketshezi lwe-Cyanide kungasongela ukuphila futhi kungaholela ekufeni.
Ngokusho kwe-NCI, ukusebenzisa i-laetrile kuhlotshaniswa nengozi enkulu ye-coma noma yokufa.
Kunokukhathazeka ukuthi i-vitamin C ingakhuphula inani le-cyanide ekhishwe e-laetrile emzimbeni futhi, ngenxa yalokho, ibangele ingozi yokudakwa.
Ucwaningo nge-Vitamin B17
Izimangalo ukuthi i-laetrile noma i-amygdalin ingazuza iziguli zomdlavuza azixhaswa ngemininingwane yemitholampilo ezwakalayo, ngokusho kombiko oshicilelwe kwiDatabase yeCorch of Reviews Systematic ngo-2011.
Kulo mbiko, ososayensi bahlaziya izifundo ezingu-69 ezazishicilelwe ngaphambilini ezihlola imiphumela ethi anti-cancer nomphumela ongase ube nemiphumela emibi ye-laetrile ne-amygdalin. Kodwa-ke, akekho kulezi zifundo ezitholakale zanele ngokwanele ukuhlangabezana nesilinganiso sababuyekezi.
Ekuphetheni kwabo, abalobi bombhalo bathi ukusetshenziswa kwe-laetrile noma i-amygdalin inomthelela omkhulu wemiphumela emibi kakhulu ephuma ku-cyanide poisoning.
Ukuze kufezeke lokho, abalobi basho ukuthi "ibhalansi yokungena engozini ye-laetrile noma i-amygdalin njengokwelashwa komdlavuza ngakho-ke kuphazamisekile."
Ezifundweni eziningana zokuqala ezanyatheliswa eminyakeni yamuva, abacwaningi baye baqaphela ukuthi i-amygdalin ingaba nezindawo ezithile zokulwa nomdlavuza.
Ucwaningo olunyatheliswa ku- Immunopharmacology ne-Immunotoxicology ngo-2013, isibonelo, lubonisa ukuthi i-amygdalin ingavikela emdlalweni wesibeletho somlomo wesibeletho. Ekuhlolweni kwamangqamuzana omuntu, abacwaningi baphawula ukuthi i-amygdalin ingase isilwe nomdlavuza womlomo wesibeletho ngokunciphisa i-apoptosis (uhlobo oluthile lwesilingo sokufa olubalulekile ekuvimbeleni ukwanda kwamangqamuzana omdlavuza).
Ngaphezu kwalokho, izifundo ezimbili zokuqala ezanyatheliswa ku- PLoS One ngo-2014 zithole ukuthi i-amygdalin ingalwela umdlavuza wesibeletho, okuyingxenye ngokuvimbela ukukhula kwe-tumor.
Ucwaningo olwengeziwe luyadingeka ngaphambi kokuba i-amygdalin inganconywa ukuvimbela noma ukwelashwa komdlavuza.
Ezinye izindlela eziya ku-Vitamin B17
Nakuba kungekho ndlela eyaziwayo yokuvimbela umdlavuza, imikhuba ethile ingasiza ekunciphiseni ingozi yomdlavuza wakho. Le mikhuba ihlanganisa ukugwema ukubhema nokusetshenziswa kogwayi, ukuhlolwa ngezimo ezinokuqapha, ukulandela ukudla okunempilo, ukuzivocavoca njalo nokugcina isisindo esinempilo .
Uma ucabanga ukusebenzisa i-vitamin B17 yokuvimbela noma ukwelashwa komdlavuza, kubalulekile ukubonisana nodokotela wakho kuqala. Ukuzitholela nokugwema noma ukubambezela ukunakekelwa okujwayelekile kungaba nemiphumela emibi.
> Imithombo:
> U-Y, u-J, u-Wang F, u-Hu J, u-Cui A, u-Wei C, u-Yang Q, u-F. "U-Amygdalin Uhlaziya I-apoptosis Emkhakheni Wengculaza Yomuntu Wase-Cervical Cell HeLa Amaseli." Immunopharmacol Immunotoxicol. 2013 Feb; 35 (1): 43-51.
> Makarević J, Rutz J, Juengel E, Kaulfuss S, Reiter M, Tsaur I, Bartsch G, Haferkamp A, Blaheta RA. "I-Amygdalin Blocks Isifo Somdlavuza Wesinye Isifo Segciwane Lesikhumba Ngokwanda Kwe-Cell In Vitro Ngokunciphisa I-Cyclin A ne-cdk2." PLoS One. 2014 Aug 19; 9 (8): e105590.
> Makarević J, Rutz J, Juengel E, Kaulfuss S, Tsaur I, Nelson K, Pfitzenmaier J, Haferkamp A, Blaheta RA1. "Izithonya zika-Amygdalin Isikhwama Sesifo Sengculazi Isikhwama Sokuvuthwa Nokuhlasela ku-Vitro." PLoS One. 2014 Oct 15; 9 (10): e110244.
> Milazzo S, Ernst E, Lejeune S, Boehm K, Horneber M. "Laetrile Treatment for Cancer." I-Cochrane Database Syst Rev. 2011 Nov 9; (11): CD005476.
> Milazzo S, Lejeune S, Ernst E. "Laetrile for Cancer: Ukubuyekezwa Okuhlelekile kobufakazi bokuKliniki." Care Cancer ukwesekwa. 2007 Jun; 15 (6): 583-95.
> National Cancer Institute. "Laetrile / Amygdalin (i-PDQ) -Isigaba Somzimba." Juni 2015.
> Ingoma Z, Xu X. "Ukucwaninga Okuthuthukisiwe Emithethweni Ye-Anti-Tumor Effects ka-Amygdalin." J Cancer Res Ther. 2014 Aug; 10 Suppl 1: 3-7.